From reactive to proactive: How Dr. Innocent Clement is redefining health tech
Healthcare has been reactive for too long, stepping in after problems escalate rather than preventing them in the first place. Dr. Innocent Clement, physician and entrepreneur, wants to change tha...
Read more.png)
You can’t aspire to what you can’t see: Furkan Karayel’s Story
In the latest RACE in STEM podcast, host Steve Fuller speaks with Furkan Karayel, a finance professional turned STEM advocate, about the importance of representation, cultural understanding, an...
Read more.png)
The Impact of Generative AI on Life Sciences Professionals
As generative AI continues to advance at an unprecedented pace, its presence across industries including life sciences is becoming increasingly significant. With this rapid evolution comes both op...
Read more
Leading with empathy: Sophie Ruddock on redefining care through tech
As part of the HealthTechQuity Spotlight Series, we sat down with Sophie Ruddock to explore her journey through tech, mission-driven leadership, and her current work transforming grief support as ...
Read more
From batch to bioreactor: How Industry 4.0 is reinventing CDMO flexibility
The Contract Development and Manufacturing Organisation (CDMO) of 2025 can no longer rely on rigid, linear batch operations. In a biotech landscape shaped by accelerated drug development, personal...
Read more
Transforming maternal health through purpose and leadership with Tracy MacNeal
In this edition of HealthTechQuity Spotlight, Perrin Joel sat down with Tracy MacNeal, CEO at Materna Medical, to talk about purpose-driven leadership, transforming maternal care, and building a M...
Read more.png)
James J. Piacentino on purpose-driven innovation in addiction science
James J. Piacentino is no stranger to building things that matter. With more than 20 years of experience across tech and healthcare, his career has spanned startup hustle, enterprise leadership, a...
Read more
Building radioligand therapy capabilities through targeted clinical hiring
A U.S. based oncology focused CRO partnered with BioTalent to build its Radioligand Therapy (RLT) function from the ground up. With RLT emerging as a cutting-edge field but lacking in experienced...
Read more
Building the future of Biotech: Dr. Ameet Nathwani on equity, innovation & impact
In this HealthTechQuity Spotlight, we spoke with Dr. Ameet Nathwani, CEO of Dewpoint Therapeutics, whose career spans clinical medicine, Big Pharma leadership, and now biotech innovation. His mis...
Read more.png)
Scaling CRA talent for North American psychiatry and neurology trials
A global full-service CRO, headquartered outside the United States, partnered with us to rapidly scale its Clinical Research Associate (CRA) workforce across North America. The goal was to suppor...
Read more.png)
How life sciences manufacturers can close the talent gap before it costs them millions
The life sciences sector is facing a critical talent challenge, and it’s costing the industry millions in lost productivity. A recent McKinsey study reveals that nearly 30% of the U.S. manufacturi...
Read more
Redesigning healthcare from the inside out: Rachel Jiang’s vision for change
In our latest HealthTechQuity Spotlight, we spoke with Rachel Jiang, SVP of Product and Technology at Taylor Care, about her journey into health tech, what drives her, and where she sees the ind...
Read more.png)
From Project Manager to President: Daryl Clark on leading with integrity
In our latest HealthTechQuity Spotlight, we sat down with Daryl Clark, President of a privately owned medical device company, to hear about his unconventional journey into healthcare, his leaders...
Read more
From Amsterdam to the NHS: A conversation with Rachel Osei on the power of support and mentorship
In the latest episode of the RACE in STEM podcast, host Steve Fuller sits down with Rachel Osei, a biomedical scientist and Programme Manager at the NIHR (National Institute for Health and Care Re...
Read more
Generative AI in Biopharma Manufacturing: Hype or Game Changer?
Over the past few weeks, James Cox, CEO of BioTalent, has participated in four major conferences and executive roundtables across the life sciences sector. At each one, a single topic dominated the...
Read more
Sandeep Athalye on Making Medicines Affordable and Innovating for the Future of Biotech
In the latest HealthTechQuity Spotlight, Sandeep Athalye, Global CEO of Kashiv Biosciences, shares his remarkable journey in drug development, his passion for affordable medicines, and his vision ...
Read more
Search by